Historical valuation data is not available at this time.
Altria Group, Inc. is a leading American corporation specializing in tobacco, cigarettes, and related products. The company holds a dominant market position in the U.S. tobacco industry, primarily through its ownership of Philip Morris USA, which manufactures Marlboro, one of the best-selling cigarette brands globally. Altria has diversified its portfolio to include smokeless tobacco products, wine, and a significant stake in Anheuser-Busch InBev. The company's competitive advantages include strong brand loyalty, extensive distribution networks, and pricing power in a highly regulated industry. Despite declining smoking rates in developed markets, Altria maintains profitability through cost management and strategic investments in reduced-risk products.
Focus on reduced-risk products (RRPs) such as heated tobacco (IQOS) and oral nicotine pouches (On!). Altria holds patents related to tobacco heating technology and has invested in cannabis through Cronos Group.
Altria offers high dividends (~8% yield) and cash flow stability but faces secular decline risks in core tobacco. Regulatory headwinds and JUUL-related losses weigh on sentiment, while smoke-free investments could provide long-term upside if executed well. Suitable for income-focused investors with moderate risk tolerance.
Altria 10-K (2022), Investor Presentations, FDA.gov, Bloomberg Tobacco Industry Reports.